Consultation on the proposed approach to provide the cannabis industry with financial relief amid the COVID-19 pandemic

From Health Canada

Current status: Closed

Opened on June 12, 2020 and closed on June 27, 2020.

As a result of the economic impact of the COVID-19 pandemic on the cannabis industry, Health Canada is considering deferring the 2020-2021 annual fee payment due date. The potential deferral would apply to the annual fee for cannabis licence holders in their first or subsequent fiscal years (those issued a licence prior to April 1, 2020). The purpose of the consultation was to solicit feedback on the proposed approach from the public and licence holders. Please refer to the Notice of Intent in the Canada Gazette, Part I, issued on June 13, 2020, for more information.

Who was the focus of this consultation

Health Canada engaged with:

Key questions for discussion

We received feedback on the potential deferral of the 2020-2021 annual fee payment due date. This potential deferral would apply to cannabis licence holders in their first or subsequent fiscal year (those issued a licence prior to April 1, 2020).

The comments will be used to inform the approach to provide the cannabis industry with financial relief amid the COVID-19 pandemic.

What we heard

Summary results of the consultation will be available in the Regulatory Impact Analysis Statement published in the Canada Gazette.

Related information

Contact us

John Clare
Director General
Strategic Policy, Cannabis
Controlled Substances and Cannabis Branch
Health Canada
Address locator 0302B
Ottawa, ON K1A 0K9
Email: hc.cannabiscrf-rcf.sc@canada.ca

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: